ARTICLES
3 Article(s)
Document(s)
Title
Scott, R. A;Freitag, D. F;Li, L;Chu, A. Y;Surendran, P;Young, R;Grarup, N;Stancakova, A;Chen, Y. N;Varga, T. V;Yaghootkar, H;Luan, J. A;Zhao, J. H;Willems, S. M;Wessel, J;Wang, S;Maruthur, N;Michailidou, K;Pirie, A;van der Lee, S. J;Gillson, C;Al Olama, A. A;Amouyel, P;Arriola, L;Arveiler, D;Aviles-Olmos, I;Balkau, B;Barricarte, A;Barroso, I;Garcia, S. B;Bis, J. C;Blankenberg, S;Boehnke, M;Boeing, H;Boerwinkle, E;Borecki, I. B;Bork-Jensen, J;Bowden, S;Caldas, C;Caslake, M;Cupples, L. A;Cruchaga, C;Czajkowski, J;den Hoed, M;Dunn, J. A;Earl, H. M;Ehret, G. B;Ferrannini, E;Ferrieres, J;Foltynie, T;Ford, I;Forouhi, N. G;Gianfagna, F;Gonzalez, C;Grioni, S;Hiller, L;Jansson, J. H;Jorgensen, M. E;Jukema, J. W;Kaaks, R;Kee, F;Kerrison, N. D;Key, T. J;Kontto, J;Kote-Jarai, Z;Kraja, A. T;Kuulasmaa, K;Kuusisto, J;Linneberg, A;Liu, C. Y;Marenne, G;Mohlke, K. L;Morris, A. P;Muir, K;Muller-Nurasyid, M;Munroe, P. B;Navarro, C;Nielsen, S. F;Nilsson, P. M;Nordestgaard, B. G;Packard, C. J;Palli, D;Panico, S;Peloso, G. M;Perola, M;Peters, A;Poole, C. J;Quiros, J. R;Rolandsson, O;Sacerdote, C;Salomaa, V;Sanchez, M. J;Sattar, N;Sharp, S. J;Sims, R;Slimani, N;Smith, J. A;Thompson, D. J;Trompet, S;Tumino, R;van der A, D. L;van der Schouw, Y. T;Virtamo, J;Walker, M;Walter, K;Abraham, J. E;Amundadottir, L. T;Aponte, J. L;Butterworth, A;Dupuis, J;Easton, D. F;Eeles, R. A;Erdmann, J;Franks, P. W;Frayling, T. M;Hansen, T;Howson, J. M. M;Jorgensen, T;Kooner, J;Laakso, M;Langenberg, C;McCarthy, M. I;Pankow, J. S;Pedersen, O;Riboli, E;Rotter, J. I;Saleheen, D;Samani, N. J;Schunkert, H;Vollenweider, P;O'Rahilly, S;Deloukas, P;Danesh, J;Goodarzi, M. O;Kathiresan, S;Meigs, J. B;Ehm, M. G;Wareham, N. J;Waterworth, D. M;Consortium, C. V. D;Consortium, Gerad-Ec, Neurology Working, Grp, Charge, Alzheimer's Dis Genetics, Consortiu, Pancreatic Canc Cohort, Consortium, European Prospective Invest Into, C;InterAct, Epic, Consortium, Charge, Consortium, C. H. D. Exome, Consortium, Cardiogram Exome
Regulatory authorities have indicated that new drugs to treat type 2 diabetes (T2D) should not be associated with an unacceptable increase in cardiovascular risk. Human genetics may be able to guide development of antidiabetic therapies by predicting...
Under lean conditions, the adipose-derived hormone leptin maintains energy balance in part through CNS-mediated increases in sympathetic outflow that enhance fat burning 1,2. Triggering of beta adrenergic receptors in adipocytes stimulates energy exp...